Regeneron Pharmaceuticals, Inc. (REGN) NASDAQ

569.90

-1.64(-0.29%)

Updated at August 05 04:00PM

Currency In USD

Valuation

Market Cap76.86B
Enterprise Value77.08B
P/E Ratio13.52
PEG Ratio-564.79
Price/Sales Ratio4.28
Price/Book Ratio2.01
Enterprise/Revenue4.33
Enterprise/EBITDA12.72

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.31
Operating Margin0.27

Management Effectiveness

Return On Assets0.12
Return On Equity0.14

Income Statement

Revenue14.2B
Revenue/Share135.24
Gross Profit12.23B
EBITDA5.32B
Net Income4.41B
Diluted EPS38.34

Balance Sheet

Total Cash7.47B
Total Cash/Share71.07
Total Debt2.71B
Total Debt/Equity0.09
Current Ratio4.6
Book Value Per Share284.86

Price History

52-Week Change-46.44
52-Week High1,211.2
52-Week Low476.49
Moving Average 50 Days540.24
Moving Average 200 Days663.68

Statistics

Average Volume1.25M
Shares Outstanding106.15M
% Held by Institutions85.9

Dividend And Splits

Trailing Annual Dividend Rate1.76
Trailing Annual Dividend Yield0.31
Payout Ratio0.04
Last Split FactorN/A
Last Split DateN/A